Abstract
EVALUATION OF ANTI-MICROBIAL (IN-VITRO) ACTIVITY OF ARICLEANSE CREAM
*Dr. S. Nipanikar, Dr. S. Agnihotri, Dr. S. Panicker and N. Shelke
ABSTRACT
Ari Healthcare Pvt. Ltd. has developed Aricleanse Cream for treatment of Acne vulgaris, Hyperpigmentation and various skin diseases. The current study was conducted to evaluate anti-microbial potential of Aricleanse Cream in comparison with various formulations (F1-F8), Clindamycin and Doxycycline against Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes. It was observed that F-1 to F-8 does not show anti-microbial activity against Staphylococcus aureus and Staphylococcus epidermidis. The zone of inhibition of Aricleanse cream was 18 mm against Staphylococcus aureus which is less as compared to Clindamycin (26 mm) and Doxycycline (30 mm). Also, the zone of inhibition of Aricleanse cream was 12 mm against Staphylococcus epidermidis which is less as compared to Clindamycin (26 mm) and Doxycycline (30 mm). Formulations F1, F-2 and Aricleanse cream showed activity against Propionobacterium acnes. Standard drugs Clindamycin and doxycycline failed to show antimicrobial activity against P. acnes. It can be concluded that Aricleanse cream possesses antibacterial activity.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here